INFECTIOUS DISEASE
May 13, 2022
Stemming Community-Associated Clostridioides difficile Infection
Recent guidelines recommend fidaxomicin as preferred therapy to reduce the recurrence of this frequently occurring healthcare-associated disease, and bezlotoxumab may be used adjunctively.
May 13, 2022
PTA: Strep Throat
April 14, 2022
Human Papillomavirus Primer for Pharmacists
April 14, 2022
COVID-19 Mixed With Flu Fueling Deadly Outcomes
April 14, 2022
PTA: Conjunctivitis
December 17, 2021
Updated Clinical Practice Guidelines for C difficile Infection in Adults
December 17, 2021
Influenza in the Age of COVID-19
October 15, 2021
Review of Selected NMEs 2021
September 1, 2021
PrEP Adherence Often Drops Among Those Who Most Need HIV Prevention
Copyright © 2000 - 2022 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.